Novel motif:125: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ |
Latest revision as of 15:13, 9 September 2013
name: | motif125_TTTAACTCGT |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0045137 | development of primary sexual characteristics | 9.071500e-9 |
GO:0035845 | photoreceptor cell outer segment organization | 2.920364e-8 |
GO:0009799 | specification of symmetry | 6.826723e-8 |
GO:0007368 | determination of left/right symmetry | 7.220677e-8 |
GO:0009855 | determination of bilateral symmetry | 9.488340e-8 |
GO:0030828 | positive regulation of cGMP biosynthetic process | 1.796383e-7 |
GO:0043252 | sodium-independent organic anion transport | 2.019459e-7 |
GO:0045981 | positive regulation of nucleotide metabolic process | 2.039902e-7 |
GO:0050925 | negative regulation of negative chemotaxis | 2.263792e-7 |
GO:0042094 | interleukin-2 biosynthetic process | 2.508267e-7 |
GO:0006970 | response to osmotic stress | 2.760853e-7 |
GO:0003127 | detection of nodal flow | 3.134171e-7 |
GO:0015742 | alpha-ketoglutarate transport | 3.885126e-7 |
GO:0045175 | basal protein localization | 3.885126e-7 |
GO:0042176 | regulation of protein catabolic process | 5.291033e-7 |
GO:0031427 | response to methotrexate | 6.050227e-7 |
GO:0007548 | sex differentiation | 6.953583e-7 |
GO:0042221 | response to chemical stimulus | 7.774146e-7 |
GO:0061136 | regulation of proteasomal protein catabolic process | 1.230560e-6 |
GO:0060807 | regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification | 1.496745e-6 |
GO:0003142 | cardiogenic plate morphogenesis | 1.496745e-6 |
GO:0030801 | positive regulation of cyclic nucleotide metabolic process | 1.782279e-6 |
GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process | 2.227923e-6 |
GO:0008207 | C21-steroid hormone metabolic process | 2.311916e-6 |
GO:0031508 | centromeric heterochromatin formation | 2.438784e-6 |
GO:0030804 | positive regulation of cyclic nucleotide biosynthetic process | 2.491413e-6 |
GO:0048608 | reproductive structure development | 3.838058e-6 |
GO:0046545 | development of primary female sexual characteristics | 4.037240e-6 |
GO:0008406 | gonad development | 4.127611e-6 |
GO:0060164 | regulation of timing of neuron differentiation | 4.130513e-6 |
GO:0035239 | tube morphogenesis | 4.636534e-6 |
GO:0048685 | negative regulation of collateral sprouting of intact axon in response to injury | 4.708765e-6 |
GO:0032488 | Cdc42 protein signal transduction | 5.166676e-6 |
GO:0046548 | retinal rod cell development | 5.556978e-6 |
GO:0000186 | activation of MAPKK activity | 5.793228e-6 |
GO:0060658 | nipple morphogenesis | 7.099159e-6 |
GO:0070541 | response to platinum ion | 7.681249e-6 |
GO:0019836 | hemolysis by symbiont of host erythrocytes | 8.735874e-6 |
GO:0030826 | regulation of cGMP biosynthetic process | 1.099819e-5 |
GO:0009410 | response to xenobiotic stimulus | 1.125497e-5 |
GO:0046660 | female sex differentiation | 1.135556e-5 |
GO:0048662 | negative regulation of smooth muscle cell proliferation | 1.220088e-5 |
GO:0021764 | amygdala development | 1.300343e-5 |
GO:0042448 | progesterone metabolic process | 1.306600e-5 |
GO:0030825 | positive regulation of cGMP metabolic process | 1.364710e-5 |
GO:0090096 | positive regulation of metanephric cap mesenchymal cell proliferation | 1.441939e-5 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 1.496403e-5 |
GO:0031647 | regulation of protein stability | 1.498130e-5 |
GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process | 1.536826e-5 |
GO:0051659 | maintenance of mitochondrion location | 1.553090e-5 |
GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep | 1.553090e-5 |
GO:0016199 | axon midline choice point recognition | 1.619497e-5 |
GO:0006805 | xenobiotic metabolic process | 1.948356e-5 |
GO:0034048 | negative regulation of protein phosphatase type 2A activity | 1.952553e-5 |
GO:0014048 | regulation of glutamate secretion | 2.158205e-5 |
GO:0030162 | regulation of proteolysis | 2.202321e-5 |
GO:0015711 | organic anion transport | 2.344617e-5 |
GO:0032623 | interleukin-2 production | 2.380925e-5 |
GO:0033700 | phospholipid efflux | 2.389379e-5 |
GO:0045023 | G0 to G1 transition | 2.436064e-5 |
GO:0065008 | regulation of biological quality | 2.701509e-5 |
GO:0071466 | cellular response to xenobiotic stimulus | 2.748301e-5 |
GO:0034377 | plasma lipoprotein particle assembly | 2.753563e-5 |
GO:0008202 | steroid metabolic process | 2.817828e-5 |
GO:0050923 | regulation of negative chemotaxis | 2.937125e-5 |
GO:0050821 | protein stabilization | 2.981058e-5 |
GO:0070986 | left/right axis specification | 3.100771e-5 |
GO:0042984 | regulation of amyloid precursor protein biosynthetic process | 3.360941e-5 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 3.458333e-5 |
GO:0009726 | detection of endogenous stimulus | 3.796738e-5 |
GO:0032805 | positive regulation of low-density lipoprotein particle receptor catabolic process | 4.339885e-5 |
GO:0009386 | translational attenuation | 4.339885e-5 |
GO:0060562 | epithelial tube morphogenesis | 4.361283e-5 |
GO:0045732 | positive regulation of protein catabolic process | 4.660601e-5 |
GO:0000715 | nucleotide-excision repair, DNA damage recognition | 4.686373e-5 |
GO:0010560 | positive regulation of glycoprotein biosynthetic process | 5.119055e-5 |
GO:0001654 | eye development | 5.179272e-5 |
GO:0034380 | high-density lipoprotein particle assembly | 5.232831e-5 |
GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process | 5.383790e-5 |
GO:0009584 | detection of visible light | 5.455642e-5 |
GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase | 5.761211e-5 |
GO:0007500 | mesodermal cell fate determination | 5.787660e-5 |
GO:0030218 | erythrocyte differentiation | 5.875628e-5 |
GO:0050983 | deoxyhypusine biosynthetic process from spermidine, using deoxyhypusine synthase | 6.357774e-5 |
GO:0042159 | lipoprotein catabolic process | 6.810395e-5 |
GO:0060649 | mammary gland bud elongation | 6.862711e-5 |
GO:0060659 | nipple sheath formation | 6.862711e-5 |
GO:0001578 | microtubule bundle formation | 7.354272e-5 |
GO:0045938 | positive regulation of circadian sleep/wake cycle, sleep | 7.357801e-5 |
GO:0042662 | negative regulation of mesodermal cell fate specification | 7.744450e-5 |
GO:0043507 | positive regulation of JUN kinase activity | 7.983043e-5 |
GO:0019748 | secondary metabolic process | 8.697199e-5 |
GO:0007168 | receptor guanylyl cyclase signaling pathway | 9.520447e-5 |
GO:0007603 | phototransduction, visible light | 9.687373e-5 |
GO:2000741 | positive regulation of mesenchymal stem cell differentiation | 9.799232e-5 |
GO:0042089 | cytokine biosynthetic process | 9.843252e-5 |
GO:0009404 | toxin metabolic process | 1.013729e-4 |
GO:0044248 | cellular catabolic process | 1.073931e-4 |
GO:0060041 | retina development in camera-type eye | 1.078896e-4 |
GO:0060956 | endocardial cell differentiation | 1.094238e-4 |
GO:0034754 | cellular hormone metabolic process | 1.112909e-4 |
GO:0060123 | regulation of growth hormone secretion | 1.283537e-4 |
GO:0016098 | monoterpenoid metabolic process | 1.313532e-4 |
GO:0050995 | negative regulation of lipid catabolic process | 1.337406e-4 |
GO:0072523 | purine-containing compound catabolic process | 1.409151e-4 |
GO:0010984 | regulation of lipoprotein particle clearance | 1.409356e-4 |
GO:0040019 | positive regulation of embryonic development | 1.506381e-4 |
GO:0034655 | nucleobase-containing compound catabolic process | 1.513471e-4 |
GO:0008585 | female gonad development | 1.573448e-4 |
GO:0003006 | developmental process involved in reproduction | 1.575818e-4 |
GO:0002244 | hemopoietic progenitor cell differentiation | 1.641388e-4 |
GO:0009056 | catabolic process | 1.648937e-4 |
GO:0034101 | erythrocyte homeostasis | 1.662522e-4 |
GO:0030728 | ovulation | 1.663579e-4 |
GO:0021891 | olfactory bulb interneuron development | 1.705192e-4 |
GO:0048505 | regulation of timing of cell differentiation | 1.778369e-4 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 1.822129e-4 |
GO:0051004 | regulation of lipoprotein lipase activity | 1.875325e-4 |
GO:0034379 | very-low-density lipoprotein particle assembly | 2.029842e-4 |
GO:0042157 | lipoprotein metabolic process | 2.048173e-4 |
GO:0050774 | negative regulation of dendrite morphogenesis | 2.128113e-4 |
GO:0060075 | regulation of resting membrane potential | 2.128113e-4 |
GO:0034047 | regulation of protein phosphatase type 2A activity | 2.128113e-4 |
GO:0015938 | coenzyme A catabolic process | 2.211732e-4 |
GO:0048683 | regulation of collateral sprouting of intact axon in response to injury | 2.251143e-4 |
GO:0034105 | positive regulation of tissue remodeling | 2.376338e-4 |
GO:0051657 | maintenance of organelle location | 2.422274e-4 |
GO:0060913 | cardiac cell fate determination | 2.474573e-4 |
GO:0014740 | negative regulation of muscle hyperplasia | 2.715067e-4 |
GO:0043010 | camera-type eye development | 2.739500e-4 |
GO:0050896 | response to stimulus | 2.781422e-4 |
GO:0010873 | positive regulation of cholesterol esterification | 2.842111e-4 |
GO:0010716 | negative regulation of extracellular matrix disassembly | 2.872411e-4 |
GO:0030823 | regulation of cGMP metabolic process | 2.956256e-4 |
GO:0002053 | positive regulation of mesenchymal cell proliferation | 3.059110e-4 |
GO:0006195 | purine nucleotide catabolic process | 3.106704e-4 |
GO:0035295 | tube development | 3.162781e-4 |
GO:0043506 | regulation of JUN kinase activity | 3.296115e-4 |
GO:0055096 | low-density lipoprotein particle mediated signaling | 3.314342e-4 |
GO:0051240 | positive regulation of multicellular organismal process | 3.357531e-4 |
GO:0061039 | ovum-producing ovary development | 3.415781e-4 |
GO:0015904 | tetracycline transport | 3.450185e-4 |
GO:0021836 | chemorepulsion involved in postnatal olfactory bulb interneuron migration | 3.483078e-4 |
GO:0001893 | maternal placenta development | 3.574520e-4 |
GO:0007507 | heart development | 3.583897e-4 |
GO:0032501 | multicellular organismal process | 3.863843e-4 |
GO:0010107 | potassium ion import | 3.905495e-4 |
GO:2000739 | regulation of mesenchymal stem cell differentiation | 3.970626e-4 |
GO:0006820 | anion transport | 4.498297e-4 |
GO:0042107 | cytokine metabolic process | 4.717208e-4 |
GO:0006811 | ion transport | 4.771401e-4 |
GO:0045541 | negative regulation of cholesterol biosynthetic process | 4.813545e-4 |
GO:0021870 | Cajal-Retzius cell differentiation | 4.813545e-4 |
GO:0009166 | nucleotide catabolic process | 4.821362e-4 |
GO:0005983 | starch catabolic process | 4.960396e-4 |
GO:0060968 | regulation of gene silencing | 5.005182e-4 |
GO:0043401 | steroid hormone mediated signaling pathway | 5.030119e-4 |
GO:0060324 | face development | 5.034037e-4 |
GO:0016198 | axon choice point recognition | 5.085443e-4 |
GO:0046700 | heterocycle catabolic process | 5.138806e-4 |
GO:0051563 | smooth endoplasmic reticulum calcium ion homeostasis | 5.307370e-4 |
GO:0034508 | centromere complex assembly | 5.307370e-4 |
GO:0014738 | regulation of muscle hyperplasia | 5.366959e-4 |
GO:0050860 | negative regulation of T cell receptor signaling pathway | 5.422638e-4 |
GO:0070493 | thrombin receptor signaling pathway | 5.474316e-4 |
GO:0051919 | positive regulation of fibrinolysis | 5.621862e-4 |
GO:0070561 | vitamin D receptor signaling pathway | 5.621862e-4 |
GO:0090184 | positive regulation of kidney development | 5.728997e-4 |
GO:0002576 | platelet degranulation | 5.966573e-4 |
GO:0003108 | negative regulation of the force of heart contraction by chemical signal | 5.991802e-4 |
GO:0009082 | branched chain family amino acid biosynthetic process | 6.001493e-4 |
GO:0046689 | response to mercury ion | 6.015314e-4 |
GO:0008105 | asymmetric protein localization | 6.033757e-4 |
GO:0001655 | urogenital system development | 6.041391e-4 |
GO:0000381 | regulation of alternative nuclear mRNA splicing, via spliceosome | 6.108096e-4 |
GO:0002639 | positive regulation of immunoglobulin production | 6.225533e-4 |
GO:0060322 | head development | 6.238040e-4 |
GO:0030540 | female genitalia development | 6.449141e-4 |
GO:0010980 | positive regulation of vitamin D 24-hydroxylase activity | 6.522037e-4 |
GO:0060823 | canonical Wnt receptor signaling pathway involved in neural plate anterior/posterior pattern formation | 6.540602e-4 |
GO:0022607 | cellular component assembly | 6.666421e-4 |
GO:0007492 | endoderm development | 6.813042e-4 |
GO:0044270 | cellular nitrogen compound catabolic process | 6.848429e-4 |
GO:0010464 | regulation of mesenchymal cell proliferation | 6.916800e-4 |
GO:0060795 | cell fate commitment involved in formation of primary germ layers | 7.002123e-4 |
GO:0072001 | renal system development | 7.140391e-4 |
GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter | 7.285359e-4 |
GO:0014745 | negative regulation of muscle adaptation | 7.285359e-4 |
GO:0009996 | negative regulation of cell fate specification | 7.384007e-4 |
GO:0002320 | lymphoid progenitor cell differentiation | 7.456298e-4 |
GO:0021772 | olfactory bulb development | 7.497648e-4 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 7.519691e-4 |
GO:0071233 | cellular response to leucine | 7.519691e-4 |
GO:0010587 | miRNA catabolic process | 7.519691e-4 |
GO:0001711 | endodermal cell fate commitment | 8.135530e-4 |
GO:0048024 | regulation of nuclear mRNA splicing, via spliceosome | 8.180961e-4 |
GO:0051716 | cellular response to stimulus | 8.381532e-4 |
GO:0010216 | maintenance of DNA methylation | 8.423904e-4 |
GO:0043114 | regulation of vascular permeability | 8.432188e-4 |
GO:0010559 | regulation of glycoprotein biosynthetic process | 8.567851e-4 |
GO:0003157 | endocardium development | 8.643439e-4 |
GO:0045995 | regulation of embryonic development | 8.673984e-4 |
GO:0060136 | embryonic process involved in female pregnancy | 8.830289e-4 |
GO:0003057 | regulation of the force of heart contraction by chemical signal | 8.830289e-4 |
GO:0030799 | regulation of cyclic nucleotide metabolic process | 8.884219e-4 |
GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity | 9.526413e-4 |
GO:0006163 | purine nucleotide metabolic process | 9.546891e-4 |
GO:0051017 | actin filament bundle assembly | 9.917713e-4 |
GO:0072521 | purine-containing compound metabolic process | 9.968027e-4 |
GO:0007512 | adult heart development | 1.004723e-3 |
GO:0022603 | regulation of anatomical structure morphogenesis | 1.027903e-3 |
GO:0050890 | cognition | 1.030824e-3 |
GO:0035556 | intracellular signal transduction | 1.038146e-3 |
GO:0010811 | positive regulation of cell-substrate adhesion | 1.039736e-3 |
GO:0006642 | triglyceride mobilization | 1.043763e-3 |
GO:0031640 | killing of cells of other organism | 1.045316e-3 |
GO:0070997 | neuron death | 1.048246e-3 |
GO:0044273 | sulfur compound catabolic process | 1.055564e-3 |
GO:0007263 | nitric oxide mediated signal transduction | 1.059505e-3 |
GO:0016998 | cell wall macromolecule catabolic process | 1.063069e-3 |
GO:0051016 | barbed-end actin filament capping | 1.083805e-3 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 1.090165e-3 |
GO:0006857 | oligopeptide transport | 1.091510e-3 |
GO:0043542 | endothelial cell migration | 1.092093e-3 |
GO:0042462 | eye photoreceptor cell development | 1.096226e-3 |
GO:0042738 | exogenous drug catabolic process | 1.110810e-3 |
GO:0061031 | endodermal digestive tract morphogenesis | 1.144957e-3 |
GO:0043584 | nose development | 1.181017e-3 |
GO:0060972 | left/right pattern formation | 1.187133e-3 |
GO:0031330 | negative regulation of cellular catabolic process | 1.194386e-3 |
GO:0007628 | adult walking behavior | 1.199858e-3 |
GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 1.235849e-3 |
GO:0002328 | pro-B cell differentiation | 1.235849e-3 |
GO:0007015 | actin filament organization | 1.252931e-3 |
GO:2000334 | positive regulation of blood microparticle formation | 1.253419e-3 |
GO:0071674 | mononuclear cell migration | 1.259804e-3 |
GO:0097006 | regulation of plasma lipoprotein particle levels | 1.340758e-3 |
GO:0051883 | killing of cells in other organism involved in symbiotic interaction | 1.371459e-3 |
GO:0044003 | modification by symbiont of host morphology or physiology | 1.374320e-3 |
GO:0048660 | regulation of smooth muscle cell proliferation | 1.395176e-3 |
GO:0044036 | cell wall macromolecule metabolic process | 1.413785e-3 |
GO:0003357 | noradrenergic neuron differentiation | 1.421266e-3 |
GO:0048643 | positive regulation of skeletal muscle tissue development | 1.434623e-3 |
GO:0046546 | development of primary male sexual characteristics | 1.436824e-3 |
GO:0071603 | endothelial cell-cell adhesion | 1.440318e-3 |
GO:0022602 | ovulation cycle process | 1.455670e-3 |
GO:0007231 | osmosensory signaling pathway | 1.477389e-3 |
GO:0035082 | axoneme assembly | 1.500723e-3 |
GO:0042461 | photoreceptor cell development | 1.524434e-3 |
GO:0060214 | endocardium formation | 1.533233e-3 |
GO:0021889 | olfactory bulb interneuron differentiation | 1.537484e-3 |
GO:0033135 | regulation of peptidyl-serine phosphorylation | 1.544496e-3 |
GO:0035088 | establishment or maintenance of apical/basal cell polarity | 1.551640e-3 |
GO:0001542 | ovulation from ovarian follicle | 1.551640e-3 |
GO:0021978 | telencephalon regionalization | 1.567954e-3 |
GO:0007256 | activation of JNKK activity | 1.570802e-3 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.584751e-3 |
GO:0019367 | fatty acid elongation, saturated fatty acid | 1.599793e-3 |
GO:0072075 | metanephric mesenchyme development | 1.611684e-3 |
GO:0002329 | pre-B cell differentiation | 1.625097e-3 |
GO:0014009 | glial cell proliferation | 1.631019e-3 |
GO:0046649 | lymphocyte activation | 1.645266e-3 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.677434e-3 |
GO:0009187 | cyclic nucleotide metabolic process | 1.713083e-3 |
GO:0034625 | fatty acid elongation, monounsaturated fatty acid | 1.729480e-3 |
GO:0009896 | positive regulation of catabolic process | 1.731575e-3 |
GO:0060541 | respiratory system development | 1.732312e-3 |
GO:0043949 | regulation of cAMP-mediated signaling | 1.752694e-3 |
GO:0018199 | peptidyl-glutamine modification | 1.784051e-3 |
GO:0006641 | triglyceride metabolic process | 1.790807e-3 |
GO:0042445 | hormone metabolic process | 1.800696e-3 |
GO:0045780 | positive regulation of bone resorption | 1.804942e-3 |
GO:0034765 | regulation of ion transmembrane transport | 1.805343e-3 |
GO:0010817 | regulation of hormone levels | 1.815449e-3 |
GO:0010872 | regulation of cholesterol esterification | 1.819430e-3 |
GO:0051646 | mitochondrion localization | 1.822162e-3 |
GO:0046549 | retinal cone cell development | 1.839463e-3 |
GO:0030183 | B cell differentiation | 1.841168e-3 |
GO:0044085 | cellular component biogenesis | 1.912286e-3 |
GO:0031122 | cytoplasmic microtubule organization | 1.927129e-3 |
GO:0023052 | signaling | 1.932723e-3 |
GO:0033152 | immunoglobulin V(D)J recombination | 1.940706e-3 |
GO:0046697 | decidualization | 1.947791e-3 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 1.968736e-3 |
GO:0032147 | activation of protein kinase activity | 1.981038e-3 |
GO:0048617 | embryonic foregut morphogenesis | 1.981063e-3 |
GO:0035810 | positive regulation of urine volume | 1.993546e-3 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 2.018684e-3 |
GO:0007565 | female pregnancy | 2.031670e-3 |
GO:0042753 | positive regulation of circadian rhythm | 2.031901e-3 |
GO:0003018 | vascular process in circulatory system | 2.093447e-3 |
GO:0035634 | response to stilbenoid | 2.107993e-3 |
GO:0014049 | positive regulation of glutamate secretion | 2.118906e-3 |
GO:0021827 | postnatal olfactory bulb interneuron migration | 2.164791e-3 |
GO:0042737 | drug catabolic process | 2.189879e-3 |
GO:0060648 | mammary gland bud morphogenesis | 2.189879e-3 |
GO:0015672 | monovalent inorganic cation transport | 2.241718e-3 |
GO:0008344 | adult locomotory behavior | 2.256068e-3 |
GO:0032608 | interferon-beta production | 2.269548e-3 |
GO:0071447 | cellular response to hydroperoxide | 2.326168e-3 |
GO:0045862 | positive regulation of proteolysis | 2.393960e-3 |
GO:0061036 | positive regulation of cartilage development | 2.441052e-3 |
GO:0043438 | acetoacetic acid metabolic process | 2.543528e-3 |
GO:0010033 | response to organic substance | 2.563327e-3 |
GO:2000121 | regulation of removal of superoxide radicals | 2.575980e-3 |
GO:0015813 | L-glutamate transport | 2.579535e-3 |
GO:0051043 | regulation of membrane protein ectodomain proteolysis | 2.595552e-3 |
GO:0045188 | regulation of circadian sleep/wake cycle, non-REM sleep | 2.604902e-3 |
GO:0010629 | negative regulation of gene expression | 2.629988e-3 |
GO:0001701 | in utero embryonic development | 2.658236e-3 |
GO:0051925 | regulation of calcium ion transport via voltage-gated calcium channel activity | 2.658252e-3 |
GO:0010470 | regulation of gastrulation | 2.671444e-3 |
GO:0002702 | positive regulation of production of molecular mediator of immune response | 2.672805e-3 |
GO:0015911 | plasma membrane long-chain fatty acid transport | 2.674884e-3 |
GO:0016447 | somatic recombination of immunoglobulin gene segments | 2.695300e-3 |
GO:0051253 | negative regulation of RNA metabolic process | 2.709345e-3 |
GO:0045922 | negative regulation of fatty acid metabolic process | 2.739814e-3 |
GO:0000003 | reproduction | 2.784626e-3 |
GO:0021517 | ventral spinal cord development | 2.859508e-3 |
GO:0021800 | cerebral cortex tangential migration | 2.882682e-3 |
GO:0007254 | JNK cascade | 2.948866e-3 |
GO:0034384 | high-density lipoprotein particle clearance | 3.041409e-3 |
GO:0031327 | negative regulation of cellular biosynthetic process | 3.050103e-3 |
GO:0002521 | leukocyte differentiation | 3.067705e-3 |
GO:0042698 | ovulation cycle | 3.091375e-3 |
GO:0001507 | acetylcholine catabolic process in synaptic cleft | 3.101242e-3 |
GO:0042412 | taurine biosynthetic process | 3.188279e-3 |
GO:0007610 | behavior | 3.223562e-3 |
GO:0046661 | male sex differentiation | 3.244358e-3 |
GO:0042113 | B cell activation | 3.309193e-3 |
GO:0022414 | reproductive process | 3.374982e-3 |
GO:0065003 | macromolecular complex assembly | 3.422774e-3 |
GO:0006638 | neutral lipid metabolic process | 3.437973e-3 |
GO:0060840 | artery development | 3.455394e-3 |
GO:0008206 | bile acid metabolic process | 3.459256e-3 |
GO:0001714 | endodermal cell fate specification | 3.461225e-3 |
GO:0050789 | regulation of biological process | 3.481966e-3 |
GO:0061188 | negative regulation of chromatin silencing at rDNA | 3.486533e-3 |
GO:0030263 | apoptotic chromosome condensation | 3.486533e-3 |
GO:0001947 | heart looping | 3.512872e-3 |
GO:2000758 | positive regulation of peptidyl-lysine acetylation | 3.543290e-3 |
GO:0048806 | genitalia development | 3.568159e-3 |
GO:2000027 | regulation of organ morphogenesis | 3.576259e-3 |
GO:0090136 | epithelial cell-cell adhesion | 3.588292e-3 |
GO:0014050 | negative regulation of glutamate secretion | 3.588292e-3 |
GO:0006730 | one-carbon metabolic process | 3.596163e-3 |
GO:0019934 | cGMP-mediated signaling | 3.607149e-3 |
GO:2000761 | positive regulation of N-terminal peptidyl-lysine acetylation | 3.610522e-3 |
GO:0035910 | ascending aorta morphogenesis | 3.610522e-3 |
GO:0034333 | adherens junction assembly | 3.619189e-3 |
GO:0002709 | regulation of T cell mediated immunity | 3.630721e-3 |
GO:0071844 | cellular component assembly at cellular level | 3.639303e-3 |
GO:0032330 | regulation of chondrocyte differentiation | 3.674549e-3 |
GO:0006639 | acylglycerol metabolic process | 3.696403e-3 |
GO:0050916 | sensory perception of sweet taste | 3.710215e-3 |
GO:0030910 | olfactory placode formation | 3.710215e-3 |
GO:0042661 | regulation of mesodermal cell fate specification | 3.727506e-3 |
GO:0009892 | negative regulation of metabolic process | 3.773705e-3 |
GO:0009143 | nucleoside triphosphate catabolic process | 3.774652e-3 |
GO:0009207 | purine ribonucleoside triphosphate catabolic process | 3.788132e-3 |
GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 3.799353e-3 |
GO:0035771 | interleukin-4-mediated signaling pathway | 3.799353e-3 |
GO:0033239 | negative regulation of cellular amine metabolic process | 3.799353e-3 |
GO:0010038 | response to metal ion | 3.806837e-3 |
GO:0016445 | somatic diversification of immunoglobulins | 3.846156e-3 |
GO:0030099 | myeloid cell differentiation | 3.887819e-3 |
GO:0007584 | response to nutrient | 3.895982e-3 |
GO:0051592 | response to calcium ion | 3.904035e-3 |
GO:0000718 | nucleotide-excision repair, DNA damage removal | 3.904682e-3 |
GO:0031123 | RNA 3'-end processing | 3.908878e-3 |
GO:0001775 | cell activation | 3.909615e-3 |
GO:0015800 | acidic amino acid transport | 3.917335e-3 |
GO:0003007 | heart morphogenesis | 3.947758e-3 |
GO:0032735 | positive regulation of interleukin-12 production | 3.987909e-3 |
GO:0030802 | regulation of cyclic nucleotide biosynthetic process | 3.989960e-3 |
GO:0006182 | cGMP biosynthetic process | 4.002670e-3 |
GO:0034383 | low-density lipoprotein particle clearance | 4.030483e-3 |
GO:0043408 | regulation of MAPKKK cascade | 4.078834e-3 |
GO:0035116 | embryonic hindlimb morphogenesis | 4.084159e-3 |
GO:0008216 | spermidine metabolic process | 4.097778e-3 |
GO:0046058 | cAMP metabolic process | 4.117050e-3 |
GO:0009146 | purine nucleoside triphosphate catabolic process | 4.125879e-3 |
GO:0010988 | regulation of low-density lipoprotein particle clearance | 4.130638e-3 |
GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway | 4.169850e-3 |
GO:0034337 | RNA folding | 4.195202e-3 |
GO:0071777 | positive regulation of cell cycle cytokinesis | 4.257136e-3 |
GO:0043249 | erythrocyte maturation | 4.257136e-3 |
GO:0071305 | cellular response to vitamin D | 4.261633e-3 |
GO:0043353 | enucleate erythrocyte differentiation | 4.315213e-3 |
GO:0030262 | apoptotic nuclear change | 4.315912e-3 |
GO:0001754 | eye photoreceptor cell differentiation | 4.321100e-3 |
GO:0009895 | negative regulation of catabolic process | 4.338240e-3 |
GO:0032467 | positive regulation of cytokinesis | 4.395917e-3 |
GO:0006713 | glucocorticoid catabolic process | 4.419581e-3 |
GO:0008652 | cellular amino acid biosynthetic process | 4.470183e-3 |
GO:0043163 | cell envelope organization | 4.480881e-3 |
GO:0000173 | inactivation of MAPK activity involved in osmosensory signaling pathway | 4.480881e-3 |
GO:0021796 | cerebral cortex regionalization | 4.480881e-3 |
GO:0030098 | lymphocyte differentiation | 4.506351e-3 |
GO:2000380 | regulation of mesoderm development | 4.525499e-3 |
GO:0060911 | cardiac cell fate commitment | 4.525499e-3 |
GO:0050856 | regulation of T cell receptor signaling pathway | 4.551460e-3 |
GO:0070302 | regulation of stress-activated protein kinase signaling cascade | 4.595279e-3 |
GO:0021795 | cerebral cortex cell migration | 4.635947e-3 |
GO:0051705 | behavioral interaction between organisms | 4.636241e-3 |
GO:0010897 | negative regulation of triglyceride catabolic process | 4.660692e-3 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 4.660692e-3 |
GO:0034381 | plasma lipoprotein particle clearance | 4.669033e-3 |
GO:0030878 | thyroid gland development | 4.669033e-3 |
GO:0031290 | retinal ganglion cell axon guidance | 4.692793e-3 |
GO:0001841 | neural tube formation | 4.712954e-3 |
GO:0060769 | positive regulation of epithelial cell proliferation involved in prostate gland development | 4.723764e-3 |
GO:0007440 | foregut morphogenesis | 4.803405e-3 |
GO:0046483 | heterocycle metabolic process | 4.829813e-3 |
GO:0045844 | positive regulation of striated muscle tissue development | 4.897111e-3 |
GO:0001502 | cartilage condensation | 4.913306e-3 |
GO:0048754 | branching morphogenesis of a tube | 4.921432e-3 |
GO:0032785 | negative regulation of transcription elongation, DNA-dependent | 4.968565e-3 |
GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway | 5.005023e-3 |
GO:0044265 | cellular macromolecule catabolic process | 5.131855e-3 |
GO:0051402 | neuron apoptosis | 5.143268e-3 |
GO:0060272 | embryonic skeletal joint morphogenesis | 5.184135e-3 |
GO:0090307 | spindle assembly involved in mitosis | 5.201650e-3 |
GO:0051151 | negative regulation of smooth muscle cell differentiation | 5.201650e-3 |
GO:0006346 | methylation-dependent chromatin silencing | 5.201650e-3 |
GO:0090183 | regulation of kidney development | 5.256707e-3 |
GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway | 5.266821e-3 |
GO:0031999 | negative regulation of fatty acid beta-oxidation | 5.268055e-3 |
GO:0000097 | sulfur amino acid biosynthetic process | 5.295975e-3 |
GO:0035385 | Roundabout signaling pathway | 5.297937e-3 |
GO:0019368 | fatty acid elongation, unsaturated fatty acid | 5.297937e-3 |
GO:0043534 | blood vessel endothelial cell migration | 5.322963e-3 |
GO:0019605 | butyrate metabolic process | 5.386378e-3 |
GO:0001838 | embryonic epithelial tube formation | 5.402447e-3 |
GO:0050794 | regulation of cellular process | 5.405883e-3 |
GO:0010454 | negative regulation of cell fate commitment | 5.430518e-3 |
GO:0043631 | RNA polyadenylation | 5.438991e-3 |
GO:0090066 | regulation of anatomical structure size | 5.499046e-3 |
GO:0046530 | photoreceptor cell differentiation | 5.516359e-3 |
GO:0030816 | positive regulation of cAMP metabolic process | 5.536636e-3 |
GO:0030851 | granulocyte differentiation | 5.561738e-3 |
GO:0007271 | synaptic transmission, cholinergic | 5.599337e-3 |
GO:0060696 | regulation of phospholipid catabolic process | 5.650152e-3 |
GO:0007155 | cell adhesion | 5.655938e-3 |
GO:0006910 | phagocytosis, recognition | 5.669422e-3 |
GO:0001658 | branching involved in ureteric bud morphogenesis | 5.683363e-3 |
GO:0009890 | negative regulation of biosynthetic process | 5.695988e-3 |
GO:0045892 | negative regulation of transcription, DNA-dependent | 5.810849e-3 |
GO:0006139 | nucleobase-containing compound metabolic process | 5.834099e-3 |
GO:0060100 | positive regulation of phagocytosis, engulfment | 5.919734e-3 |
GO:0008210 | estrogen metabolic process | 6.069477e-3 |
GO:0033602 | negative regulation of dopamine secretion | 6.080971e-3 |
GO:0030534 | adult behavior | 6.094272e-3 |
GO:0042158 | lipoprotein biosynthetic process | 6.111030e-3 |
GO:0044281 | small molecule metabolic process | 6.135642e-3 |
GO:0034641 | cellular nitrogen compound metabolic process | 6.199481e-3 |
GO:0000320 | re-entry into mitotic cell cycle | 6.249113e-3 |
GO:0008608 | attachment of spindle microtubules to kinetochore | 6.249113e-3 |
GO:0009154 | purine ribonucleotide catabolic process | 6.294587e-3 |
GO:0001822 | kidney development | 6.447267e-3 |
GO:0010896 | regulation of triglyceride catabolic process | 6.591138e-3 |
GO:0051610 | serotonin uptake | 6.619734e-3 |
GO:0009268 | response to pH | 6.722271e-3 |
GO:0071404 | cellular response to low-density lipoprotein particle stimulus | 6.726316e-3 |
GO:0042147 | retrograde transport, endosome to Golgi | 6.726379e-3 |
GO:0008211 | glucocorticoid metabolic process | 6.726379e-3 |
GO:0048745 | smooth muscle tissue development | 6.761263e-3 |
GO:0048671 | negative regulation of collateral sprouting | 6.771535e-3 |
GO:0009261 | ribonucleotide catabolic process | 6.878790e-3 |
GO:0044060 | regulation of endocrine process | 6.897478e-3 |
GO:0051258 | protein polymerization | 6.912235e-3 |
GO:0071383 | cellular response to steroid hormone stimulus | 6.937397e-3 |
GO:0046328 | regulation of JNK cascade | 6.957275e-3 |
GO:0046323 | glucose import | 7.006877e-3 |
GO:0045746 | negative regulation of Notch signaling pathway | 7.023008e-3 |
GO:0003211 | cardiac ventricle formation | 7.142229e-3 |
GO:0006376 | mRNA splice site selection | 7.148294e-3 |
GO:0006308 | DNA catabolic process | 7.157186e-3 |
GO:0015914 | phospholipid transport | 7.172598e-3 |
GO:0051983 | regulation of chromosome segregation | 7.216615e-3 |
GO:0006378 | mRNA polyadenylation | 7.286242e-3 |
GO:0072175 | epithelial tube formation | 7.313965e-3 |
GO:0044029 | hypomethylation of CpG island | 7.314100e-3 |
GO:0042699 | follicle-stimulating hormone signaling pathway | 7.314100e-3 |
GO:0002118 | aggressive behavior | 7.314100e-3 |
GO:0035050 | embryonic heart tube development | 7.320563e-3 |
GO:0030219 | megakaryocyte differentiation | 7.363764e-3 |
GO:0051046 | regulation of secretion | 7.367196e-3 |
GO:0048513 | organ development | 7.376228e-3 |
GO:2000113 | negative regulation of cellular macromolecule biosynthetic process | 7.376343e-3 |
GO:0014012 | peripheral nervous system axon regeneration | 7.424900e-3 |
GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA | 7.428040e-3 |
GO:0072215 | regulation of metanephros development | 7.446353e-3 |
GO:0045626 | negative regulation of T-helper 1 cell differentiation | 7.502820e-3 |
GO:0016080 | synaptic vesicle targeting | 7.502820e-3 |
GO:0003084 | positive regulation of systemic arterial blood pressure | 7.537996e-3 |
GO:0060675 | ureteric bud morphogenesis | 7.557978e-3 |
GO:0048844 | artery morphogenesis | 7.630253e-3 |
GO:0008152 | metabolic process | 7.675516e-3 |
GO:0001906 | cell killing | 7.701910e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0055090 | acylglycerol homeostasis | 6.619744e-22 |
GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling | 5.164954e-18 |
GO:0006982 | response to lipid hydroperoxide | 3.479371e-17 |
GO:0002227 | innate immune response in mucosa | 4.689712e-17 |
GO:0034370 | triglyceride-rich lipoprotein particle remodeling | 1.420893e-16 |
GO:0034372 | very-low-density lipoprotein particle remodeling | 7.189296e-16 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 2.572523e-15 |
GO:0034442 | regulation of lipoprotein oxidation | 5.588786e-15 |
GO:0070328 | triglyceride homeostasis | 9.542080e-15 |
GO:0002385 | mucosal immune response | 2.325336e-14 |
GO:0002251 | organ or tissue specific immune response | 4.388539e-14 |
GO:2000761 | positive regulation of N-terminal peptidyl-lysine acetylation | 4.571485e-14 |
GO:0035910 | ascending aorta morphogenesis | 4.571485e-14 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 4.571485e-14 |
GO:0042632 | cholesterol homeostasis | 7.565665e-14 |
GO:0046464 | acylglycerol catabolic process | 8.365786e-14 |
GO:0010901 | regulation of very-low-density lipoprotein particle remodeling | 1.141773e-13 |
GO:0046503 | glycerolipid catabolic process | 2.271311e-13 |
GO:0019433 | triglyceride catabolic process | 2.903792e-13 |
GO:0090208 | positive regulation of triglyceride metabolic process | 6.595858e-13 |
GO:0060563 | neuroepithelial cell differentiation | 8.167913e-13 |
GO:0042246 | tissue regeneration | 1.111683e-12 |
GO:0050996 | positive regulation of lipid catabolic process | 1.608085e-12 |
GO:0055088 | lipid homeostasis | 1.734652e-12 |
GO:0002328 | pro-B cell differentiation | 1.993073e-12 |
GO:0046826 | negative regulation of protein export from nucleus | 2.348205e-12 |
GO:0010898 | positive regulation of triglyceride catabolic process | 2.348205e-12 |
GO:0042769 | DNA damage response, detection of DNA damage | 2.436550e-12 |
GO:0051248 | negative regulation of protein metabolic process | 2.557781e-12 |
GO:0003357 | noradrenergic neuron differentiation | 2.777782e-12 |
GO:0030300 | regulation of intestinal cholesterol absorption | 3.163108e-12 |
GO:0044240 | multicellular organismal lipid catabolic process | 4.438365e-12 |
GO:0031099 | regeneration | 4.871713e-12 |
GO:0044242 | cellular lipid catabolic process | 4.996910e-12 |
GO:0050746 | regulation of lipoprotein metabolic process | 6.035261e-12 |
GO:0003289 | atrial septum primum morphogenesis | 7.019368e-12 |
GO:0043252 | sodium-independent organic anion transport | 1.247459e-11 |
GO:0051006 | positive regulation of lipoprotein lipase activity | 1.263272e-11 |
GO:0090201 | negative regulation of release of cytochrome c from mitochondria | 4.110213e-11 |
GO:0032269 | negative regulation of cellular protein metabolic process | 4.751025e-11 |
GO:0010823 | negative regulation of mitochondrion organization | 6.713283e-11 |
GO:0045723 | positive regulation of fatty acid biosynthetic process | 7.986137e-11 |
GO:0014009 | glial cell proliferation | 1.084287e-10 |
GO:0010896 | regulation of triglyceride catabolic process | 1.507491e-10 |
GO:0033194 | response to hydroperoxide | 1.907327e-10 |
GO:0043691 | reverse cholesterol transport | 3.249092e-10 |
GO:0003183 | mitral valve morphogenesis | 4.689189e-10 |
GO:0007159 | leukocyte cell-cell adhesion | 5.684575e-10 |
GO:0003211 | cardiac ventricle formation | 6.135900e-10 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 9.801771e-10 |
GO:0003207 | cardiac chamber formation | 9.843747e-10 |
GO:0072404 | signal transduction involved in G1/S transition checkpoint | 1.295947e-9 |
GO:0060413 | atrial septum morphogenesis | 1.327077e-9 |
GO:0019827 | stem cell maintenance | 1.564483e-9 |
GO:2000758 | positive regulation of peptidyl-lysine acetylation | 1.662689e-9 |
GO:0072422 | signal transduction involved in DNA damage checkpoint | 1.783657e-9 |
GO:0072395 | signal transduction involved in cell cycle checkpoint | 2.123292e-9 |
GO:0045919 | positive regulation of cytolysis | 2.485846e-9 |
GO:0031400 | negative regulation of protein modification process | 2.737088e-9 |
GO:0042157 | lipoprotein metabolic process | 2.818427e-9 |
GO:0010873 | positive regulation of cholesterol esterification | 2.921241e-9 |
GO:0048864 | stem cell development | 3.599626e-9 |
GO:0065005 | protein-lipid complex assembly | 3.692186e-9 |
GO:0090207 | regulation of triglyceride metabolic process | 4.364385e-9 |
GO:0044243 | multicellular organismal catabolic process | 4.543636e-9 |
GO:0046825 | regulation of protein export from nucleus | 5.012771e-9 |
GO:0031647 | regulation of protein stability | 5.277924e-9 |
GO:0044058 | regulation of digestive system process | 5.404868e-9 |
GO:2000756 | regulation of peptidyl-lysine acetylation | 5.756019e-9 |
GO:0035634 | response to stilbenoid | 6.490205e-9 |
GO:0034369 | plasma lipoprotein particle remodeling | 7.332133e-9 |
GO:0032232 | negative regulation of actin filament bundle assembly | 8.000247e-9 |
GO:0035904 | aorta development | 8.468345e-9 |
GO:0010872 | regulation of cholesterol esterification | 1.202973e-8 |
GO:0033700 | phospholipid efflux | 1.290539e-8 |
GO:0070373 | negative regulation of ERK1 and ERK2 cascade | 1.383933e-8 |
GO:0032368 | regulation of lipid transport | 1.795418e-8 |
GO:0060739 | mesenchymal-epithelial cell signaling involved in prostate gland development | 1.953034e-8 |
GO:0003283 | atrial septum development | 2.433805e-8 |
GO:0035909 | aorta morphogenesis | 2.725595e-8 |
GO:0044241 | lipid digestion | 3.312008e-8 |
GO:0031018 | endocrine pancreas development | 3.322609e-8 |
GO:0016042 | lipid catabolic process | 4.332460e-8 |
GO:0048878 | chemical homeostasis | 4.579427e-8 |
GO:0060191 | regulation of lipase activity | 4.882895e-8 |
GO:0031397 | negative regulation of protein ubiquitination | 4.942369e-8 |
GO:0002320 | lymphoid progenitor cell differentiation | 5.359819e-8 |
GO:0051004 | regulation of lipoprotein lipase activity | 6.162322e-8 |
GO:0090199 | regulation of release of cytochrome c from mitochondria | 9.153616e-8 |
GO:0035019 | somatic stem cell maintenance | 1.040106e-7 |
GO:0031016 | pancreas development | 1.315943e-7 |
GO:0042744 | hydrogen peroxide catabolic process | 1.496631e-7 |
GO:0060174 | limb bud formation | 1.572600e-7 |
GO:0019430 | removal of superoxide radicals | 1.680436e-7 |
GO:0021764 | amygdala development | 1.939482e-7 |
GO:0050994 | regulation of lipid catabolic process | 2.244517e-7 |
GO:0050821 | protein stabilization | 2.370828e-7 |
GO:0003215 | cardiac right ventricle morphogenesis | 2.569425e-7 |
GO:0008202 | steroid metabolic process | 2.622525e-7 |
GO:0071827 | plasma lipoprotein particle organization | 2.647000e-7 |
GO:0006641 | triglyceride metabolic process | 2.772657e-7 |
GO:0060412 | ventricular septum morphogenesis | 3.517870e-7 |
GO:0010519 | negative regulation of phospholipase activity | 4.025491e-7 |
GO:0031571 | mitotic cell cycle G1/S transition DNA damage checkpoint | 4.059037e-7 |
GO:0071333 | cellular response to glucose stimulus | 4.073971e-7 |
GO:0006638 | neutral lipid metabolic process | 4.283190e-7 |
GO:0097006 | regulation of plasma lipoprotein particle levels | 5.095660e-7 |
GO:0030098 | lymphocyte differentiation | 5.491854e-7 |
GO:0006639 | acylglycerol metabolic process | 6.057765e-7 |
GO:0042770 | signal transduction in response to DNA damage | 6.459230e-7 |
GO:0045923 | positive regulation of fatty acid metabolic process | 7.396489e-7 |
GO:0031100 | organ regeneration | 7.902747e-7 |
GO:0008203 | cholesterol metabolic process | 8.359306e-7 |
GO:0002521 | leukocyte differentiation | 8.616652e-7 |
GO:0042743 | hydrogen peroxide metabolic process | 1.092107e-6 |
GO:0001678 | cellular glucose homeostasis | 1.142197e-6 |
GO:0000303 | response to superoxide | 1.142417e-6 |
GO:0016125 | sterol metabolic process | 1.173198e-6 |
GO:0006801 | superoxide metabolic process | 1.305251e-6 |
GO:0070842 | aggresome assembly | 1.326733e-6 |
GO:0010821 | regulation of mitochondrion organization | 1.344304e-6 |
GO:0009896 | positive regulation of catabolic process | 1.391151e-6 |
GO:0006396 | RNA processing | 1.579200e-6 |
GO:0002244 | hemopoietic progenitor cell differentiation | 1.764723e-6 |
GO:0021517 | ventral spinal cord development | 2.391739e-6 |
GO:0032374 | regulation of cholesterol transport | 2.484260e-6 |
GO:0042304 | regulation of fatty acid biosynthetic process | 2.631511e-6 |
GO:0060840 | artery development | 2.800956e-6 |
GO:0048863 | stem cell differentiation | 2.834990e-6 |
GO:0000305 | response to oxygen radical | 3.069585e-6 |
GO:0071779 | G1/S transition checkpoint | 3.180052e-6 |
GO:0060193 | positive regulation of lipase activity | 3.263171e-6 |
GO:0071322 | cellular response to carbohydrate stimulus | 3.311803e-6 |
GO:0042221 | response to chemical stimulus | 3.459223e-6 |
GO:0031427 | response to methotrexate | 3.524803e-6 |
GO:0045834 | positive regulation of lipid metabolic process | 3.534946e-6 |
GO:0090317 | negative regulation of intracellular protein transport | 3.683954e-6 |
GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase | 3.780977e-6 |
GO:0006353 | transcription termination, DNA-dependent | 3.780977e-6 |
GO:0001788 | antibody-dependent cellular cytotoxicity | 4.356878e-6 |
GO:0003179 | heart valve morphogenesis | 4.396380e-6 |
GO:0031331 | positive regulation of cellular catabolic process | 4.498113e-6 |
GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 4.563377e-6 |
GO:0009894 | regulation of catabolic process | 5.063392e-6 |
GO:0033344 | cholesterol efflux | 5.194477e-6 |
GO:0048844 | artery morphogenesis | 5.205712e-6 |
GO:0042592 | homeostatic process | 5.440040e-6 |
GO:0071158 | positive regulation of cell cycle arrest | 5.462385e-6 |
GO:0032387 | negative regulation of intracellular transport | 5.491881e-6 |
GO:0048485 | sympathetic nervous system development | 5.535858e-6 |
GO:0046470 | phosphatidylcholine metabolic process | 5.535858e-6 |
GO:0031508 | centromeric heterochromatin formation | 5.956483e-6 |
GO:0060411 | cardiac septum morphogenesis | 6.105466e-6 |
GO:0046823 | negative regulation of nucleocytoplasmic transport | 6.134695e-6 |
GO:0042843 | D-xylose catabolic process | 6.389316e-6 |
GO:0003170 | heart valve development | 6.578012e-6 |
GO:0016567 | protein ubiquitination | 6.671598e-6 |
GO:0014067 | negative regulation of phosphatidylinositol 3-kinase cascade | 6.726085e-6 |
GO:0046889 | positive regulation of lipid biosynthetic process | 6.853048e-6 |
GO:0031575 | mitotic cell cycle G1/S transition checkpoint | 6.875284e-6 |
GO:0021522 | spinal cord motor neuron differentiation | 7.770447e-6 |
GO:0014904 | myotube cell development | 8.047872e-6 |
GO:0001810 | regulation of type I hypersensitivity | 8.047872e-6 |
GO:0000422 | mitochondrion degradation | 8.047872e-6 |
GO:0006662 | glycerol ether metabolic process | 8.448261e-6 |
GO:0045321 | leukocyte activation | 1.018119e-5 |
GO:0045023 | G0 to G1 transition | 1.051956e-5 |
GO:0046649 | lymphocyte activation | 1.084619e-5 |
GO:0051583 | dopamine uptake | 1.163713e-5 |
GO:0042268 | regulation of cytolysis | 1.163713e-5 |
GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 1.176214e-5 |
GO:0030263 | apoptotic chromosome condensation | 1.361827e-5 |
GO:0072331 | signal transduction by p53 class mediator | 1.393724e-5 |
GO:0042439 | ethanolamine-containing compound metabolic process | 1.410731e-5 |
GO:0006110 | regulation of glycolysis | 1.543026e-5 |
GO:0072593 | reactive oxygen species metabolic process | 1.594228e-5 |
GO:0001933 | negative regulation of protein phosphorylation | 1.659322e-5 |
GO:0002526 | acute inflammatory response | 1.677950e-5 |
GO:0033554 | cellular response to stress | 1.733902e-5 |
GO:0009992 | cellular water homeostasis | 1.740161e-5 |
GO:0050851 | antigen receptor-mediated signaling pathway | 1.817515e-5 |
GO:0006629 | lipid metabolic process | 1.942900e-5 |
GO:0010216 | maintenance of DNA methylation | 2.030766e-5 |
GO:0007093 | mitotic cell cycle checkpoint | 2.307626e-5 |
GO:0002891 | positive regulation of immunoglobulin mediated immune response | 2.469491e-5 |
GO:0051224 | negative regulation of protein transport | 2.565358e-5 |
GO:0045821 | positive regulation of glycolysis | 2.623762e-5 |
GO:0014896 | muscle hypertrophy | 2.765171e-5 |
GO:0042100 | B cell proliferation | 2.822694e-5 |
GO:0030217 | T cell differentiation | 3.064255e-5 |
GO:0060741 | prostate gland stromal morphogenesis | 3.072012e-5 |
GO:0006397 | mRNA processing | 3.188797e-5 |
GO:0001510 | RNA methylation | 3.300555e-5 |
GO:0045079 | negative regulation of chemokine biosynthetic process | 3.379915e-5 |
GO:0001812 | positive regulation of type I hypersensitivity | 3.379915e-5 |
GO:0001777 | T cell homeostatic proliferation | 3.452903e-5 |
GO:0031329 | regulation of cellular catabolic process | 3.536490e-5 |
GO:0035630 | bone mineralization involved in bone maturation | 3.552205e-5 |
GO:0030301 | cholesterol transport | 3.563764e-5 |
GO:0032446 | protein modification by small protein conjugation | 3.651671e-5 |
GO:0051128 | regulation of cellular component organization | 3.667995e-5 |
GO:0045936 | negative regulation of phosphate metabolic process | 4.122379e-5 |
GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis | 4.132015e-5 |
GO:0030104 | water homeostasis | 4.172293e-5 |
GO:0045940 | positive regulation of steroid metabolic process | 4.271817e-5 |
GO:0002429 | immune response-activating cell surface receptor signaling pathway | 4.345360e-5 |
GO:0003281 | ventricular septum development | 4.370612e-5 |
GO:0015914 | phospholipid transport | 4.605809e-5 |
GO:0042113 | B cell activation | 4.607036e-5 |
GO:0008033 | tRNA processing | 4.709559e-5 |
GO:0018904 | organic ether metabolic process | 4.868485e-5 |
GO:0015844 | monoamine transport | 4.975405e-5 |
GO:0042326 | negative regulation of phosphorylation | 5.259114e-5 |
GO:0010506 | regulation of autophagy | 5.636650e-5 |
GO:0006576 | cellular biogenic amine metabolic process | 5.715654e-5 |
GO:0030488 | tRNA methylation | 5.795591e-5 |
GO:0006379 | mRNA cleavage | 6.103908e-5 |
GO:0034470 | ncRNA processing | 6.135120e-5 |
GO:0045725 | positive regulation of glycogen biosynthetic process | 6.248032e-5 |
GO:0050853 | B cell receptor signaling pathway | 6.748793e-5 |
GO:0002768 | immune response-regulating cell surface receptor signaling pathway | 6.798365e-5 |
GO:0042060 | wound healing | 7.033922e-5 |
GO:0001844 | protein insertion into mitochondrial membrane involved in induction of apoptosis | 7.181890e-5 |
GO:0014012 | peripheral nervous system axon regeneration | 7.588501e-5 |
GO:0072368 | regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter | 8.473731e-5 |
GO:0072362 | regulation of glycolysis by negative regulation of transcription from RNA polymerase II promoter | 8.473731e-5 |
GO:0043931 | ossification involved in bone maturation | 8.853070e-5 |
GO:0070301 | cellular response to hydrogen peroxide | 9.554100e-5 |
GO:0044236 | multicellular organismal metabolic process | 9.641934e-5 |
GO:0003279 | cardiac septum development | 9.925232e-5 |
GO:0031055 | chromatin remodeling at centromere | 1.001916e-4 |
GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 1.010673e-4 |
GO:0014066 | regulation of phosphatidylinositol 3-kinase cascade | 1.011667e-4 |
GO:0000209 | protein polyubiquitination | 1.022905e-4 |
GO:0051606 | detection of stimulus | 1.062237e-4 |
GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change | 1.094698e-4 |
GO:0032879 | regulation of localization | 1.101368e-4 |
GO:0050789 | regulation of biological process | 1.110500e-4 |
GO:0009725 | response to hormone stimulus | 1.112563e-4 |
GO:0001915 | negative regulation of T cell mediated cytotoxicity | 1.141981e-4 |
GO:0010605 | negative regulation of macromolecule metabolic process | 1.147189e-4 |
GO:0001805 | positive regulation of type III hypersensitivity | 1.172553e-4 |
GO:0032853 | positive regulation of Ran GTPase activity | 1.183703e-4 |
GO:0051246 | regulation of protein metabolic process | 1.199106e-4 |
GO:0031396 | regulation of protein ubiquitination | 1.220844e-4 |
GO:0010608 | posttranscriptional regulation of gene expression | 1.259778e-4 |
GO:0001775 | cell activation | 1.281768e-4 |
GO:0043407 | negative regulation of MAP kinase activity | 1.310684e-4 |
GO:0050852 | T cell receptor signaling pathway | 1.312317e-4 |
GO:2000045 | regulation of G1/S transition of mitotic cell cycle | 1.354029e-4 |
GO:0009749 | response to glucose stimulus | 1.360080e-4 |
GO:0030183 | B cell differentiation | 1.382853e-4 |
GO:0035520 | monoubiquitinated protein deubiquitination | 1.390450e-4 |
GO:0070977 | bone maturation | 1.394579e-4 |
GO:0090218 | positive regulation of lipid kinase activity | 1.402959e-4 |
GO:0008206 | bile acid metabolic process | 1.518713e-4 |
GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway | 1.525117e-4 |
GO:0003208 | cardiac ventricle morphogenesis | 1.571091e-4 |
GO:0051204 | protein insertion into mitochondrial membrane | 1.579812e-4 |
GO:0006808 | regulation of nitrogen utilization | 1.579812e-4 |
GO:0002757 | immune response-activating signal transduction | 1.607812e-4 |
GO:0010676 | positive regulation of cellular carbohydrate metabolic process | 1.699215e-4 |
GO:0042063 | gliogenesis | 1.700148e-4 |
GO:0045727 | positive regulation of translation | 1.714173e-4 |
GO:0034113 | heterotypic cell-cell adhesion | 1.779650e-4 |
GO:0034349 | glial cell apoptosis | 1.799770e-4 |
GO:0009743 | response to carbohydrate stimulus | 1.844090e-4 |
GO:0042417 | dopamine metabolic process | 1.897852e-4 |
GO:0021515 | cell differentiation in spinal cord | 1.943513e-4 |
GO:0051497 | negative regulation of stress fiber assembly | 1.951345e-4 |
GO:0032024 | positive regulation of insulin secretion | 1.956402e-4 |
GO:0002710 | negative regulation of T cell mediated immunity | 2.015761e-4 |
GO:0070936 | protein K48-linked ubiquitination | 2.106523e-4 |
GO:0014834 | satellite cell maintenance involved in skeletal muscle regeneration | 2.111966e-4 |
GO:0031401 | positive regulation of protein modification process | 2.138948e-4 |
GO:0060452 | positive regulation of cardiac muscle contraction | 2.148669e-4 |
GO:0048483 | autonomic nervous system development | 2.189987e-4 |
GO:0044255 | cellular lipid metabolic process | 2.270175e-4 |
GO:0045446 | endothelial cell differentiation | 2.302256e-4 |
GO:0003209 | cardiac atrium morphogenesis | 2.325877e-4 |
GO:0006661 | phosphatidylinositol biosynthetic process | 2.345556e-4 |
GO:0006921 | cellular component disassembly involved in apoptosis | 2.345556e-4 |
GO:0070875 | positive regulation of glycogen metabolic process | 2.370769e-4 |
GO:0006950 | response to stress | 2.503556e-4 |
GO:0002352 | B cell negative selection | 2.622195e-4 |
GO:0051049 | regulation of transport | 2.675640e-4 |
GO:0006370 | mRNA capping | 2.709644e-4 |
GO:0002764 | immune response-regulating signaling pathway | 2.804854e-4 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 2.808127e-4 |
GO:0055082 | cellular chemical homeostasis | 2.974534e-4 |
GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin | 3.049985e-4 |
GO:0006690 | icosanoid metabolic process | 3.076412e-4 |
GO:0060318 | definitive erythrocyte differentiation | 3.092475e-4 |
GO:0090049 | regulation of cell migration involved in sprouting angiogenesis | 3.092475e-4 |
GO:0003009 | skeletal muscle contraction | 3.215897e-4 |
GO:0042110 | T cell activation | 3.239841e-4 |
GO:0071156 | regulation of cell cycle arrest | 3.268869e-4 |
GO:0051873 | killing by host of symbiont cells | 3.385843e-4 |
GO:0009746 | response to hexose stimulus | 3.400636e-4 |
GO:0016337 | cell-cell adhesion | 3.530393e-4 |
GO:0002438 | acute inflammatory response to antigenic stimulus | 3.572290e-4 |
GO:0050855 | regulation of B cell receptor signaling pathway | 3.586029e-4 |
GO:0009892 | negative regulation of metabolic process | 3.608550e-4 |
GO:0009719 | response to endogenous stimulus | 3.622033e-4 |
GO:0070647 | protein modification by small protein conjugation or removal | 3.641131e-4 |
GO:0043086 | negative regulation of catalytic activity | 3.662766e-4 |
GO:0034392 | negative regulation of smooth muscle cell apoptosis | 3.700545e-4 |
GO:0043471 | regulation of cellular carbohydrate catabolic process | 3.723171e-4 |
GO:0001909 | leukocyte mediated cytotoxicity | 3.758936e-4 |
GO:0006680 | glucosylceramide catabolic process | 3.786588e-4 |
GO:0046486 | glycerolipid metabolic process | 3.845386e-4 |
GO:0042628 | mating plug formation | 3.895539e-4 |
GO:0003158 | endothelium development | 3.967192e-4 |
GO:0030262 | apoptotic nuclear change | 4.172074e-4 |
GO:0006974 | response to DNA damage stimulus | 4.204829e-4 |
GO:0006650 | glycerophospholipid metabolic process | 4.321489e-4 |
GO:0060564 | negative regulation of mitotic anaphase-promoting complex activity | 4.489138e-4 |
GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway | 4.489138e-4 |
GO:0051726 | regulation of cell cycle | 4.517239e-4 |
GO:0048661 | positive regulation of smooth muscle cell proliferation | 4.602426e-4 |
GO:0031047 | gene silencing by RNA | 4.638990e-4 |
GO:0010907 | positive regulation of glucose metabolic process | 4.716418e-4 |
GO:0001906 | cell killing | 4.736683e-4 |
GO:0003230 | cardiac atrium development | 5.174980e-4 |
GO:0046666 | retinal cell programmed cell death | 5.279833e-4 |
GO:0002358 | B cell homeostatic proliferation | 5.279833e-4 |
GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin | 5.339360e-4 |
GO:0000075 | cell cycle checkpoint | 5.361417e-4 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 5.488451e-4 |
GO:0002467 | germinal center formation | 5.571883e-4 |
GO:0060426 | lung vasculature development | 5.668305e-4 |
GO:0010639 | negative regulation of organelle organization | 5.814395e-4 |
GO:0034284 | response to monosaccharide stimulus | 5.853808e-4 |
GO:0032787 | monocarboxylic acid metabolic process | 5.854343e-4 |
GO:0021510 | spinal cord development | 5.893898e-4 |
GO:0060509 | Type I pneumocyte differentiation | 6.126720e-4 |
GO:0070947 | neutrophil mediated killing of fungus | 6.164675e-4 |
GO:0035914 | skeletal muscle cell differentiation | 6.190007e-4 |
GO:0090277 | positive regulation of peptide hormone secretion | 6.286448e-4 |
GO:0002823 | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 6.336871e-4 |
GO:0007155 | cell adhesion | 6.389259e-4 |
GO:0044265 | cellular macromolecule catabolic process | 6.491249e-4 |
GO:0034660 | ncRNA metabolic process | 6.514235e-4 |
GO:0015872 | dopamine transport | 6.527912e-4 |
GO:0060164 | regulation of timing of neuron differentiation | 6.527912e-4 |
GO:0006497 | protein lipidation | 6.633529e-4 |
GO:0048678 | response to axon injury | 6.636384e-4 |
GO:0002118 | aggressive behavior | 6.691432e-4 |
GO:0008052 | sensory organ boundary specification | 6.902366e-4 |
GO:0007402 | ganglion mother cell fate determination | 6.902366e-4 |
GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport | 7.027088e-4 |
GO:0019217 | regulation of fatty acid metabolic process | 7.093237e-4 |
GO:0030097 | hemopoiesis | 7.107422e-4 |
GO:0048597 | post-embryonic camera-type eye morphogenesis | 7.149708e-4 |
GO:0042732 | D-xylose metabolic process | 7.149708e-4 |
GO:0009887 | organ morphogenesis | 7.342729e-4 |
GO:0021819 | layer formation in cerebral cortex | 7.394609e-4 |
GO:0005979 | regulation of glycogen biosynthetic process | 7.438727e-4 |
GO:0022610 | biological adhesion | 7.486863e-4 |
GO:0043409 | negative regulation of MAPKKK cascade | 7.549298e-4 |
GO:0016071 | mRNA metabolic process | 7.689693e-4 |
GO:0070997 | neuron death | 7.699947e-4 |
GO:0002793 | positive regulation of peptide secretion | 7.741316e-4 |
GO:0032231 | regulation of actin filament bundle assembly | 7.993426e-4 |
GO:0009452 | RNA capping | 8.151504e-4 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 8.241005e-4 |
GO:0002889 | regulation of immunoglobulin mediated immune response | 8.382526e-4 |
GO:0001516 | prostaglandin biosynthetic process | 8.451304e-4 |
GO:0006953 | acute-phase response | 8.550946e-4 |
GO:0048015 | phosphatidylinositol-mediated signaling | 8.550946e-4 |
GO:0010033 | response to organic substance | 8.614190e-4 |
GO:0001662 | behavioral fear response | 8.956333e-4 |
GO:0034508 | centromere complex assembly | 8.964647e-4 |
GO:0045657 | positive regulation of monocyte differentiation | 8.964647e-4 |
GO:0001963 | synaptic transmission, dopaminergic | 9.392711e-4 |
GO:0002209 | behavioral defense response | 9.507012e-4 |
GO:0009611 | response to wounding | 9.606985e-4 |
GO:0043467 | regulation of generation of precursor metabolites and energy | 9.689896e-4 |
GO:0009893 | positive regulation of metabolic process | 9.915237e-4 |
GO:0048583 | regulation of response to stimulus | 1.010822e-3 |
GO:0051247 | positive regulation of protein metabolic process | 1.033840e-3 |
GO:0044092 | negative regulation of molecular function | 1.053432e-3 |
GO:0070943 | neutrophil mediated killing of symbiont cell | 1.076676e-3 |
GO:0046340 | diacylglycerol catabolic process | 1.076676e-3 |
GO:0019987 | negative regulation of anti-apoptosis | 1.076995e-3 |
GO:0002820 | negative regulation of adaptive immune response | 1.084524e-3 |
GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway | 1.084524e-3 |
GO:0051593 | response to folic acid | 1.099414e-3 |
GO:0001504 | neurotransmitter uptake | 1.104522e-3 |
GO:0031324 | negative regulation of cellular metabolic process | 1.111314e-3 |
GO:0051482 | elevation of cytosolic calcium ion concentration involved in G-protein signaling coupled to IP3 second messenger | 1.115443e-3 |
GO:0006417 | regulation of translation | 1.119828e-3 |
GO:0007194 | negative regulation of adenylate cyclase activity | 1.122148e-3 |
GO:0006693 | prostaglandin metabolic process | 1.141430e-3 |
GO:0010741 | negative regulation of intracellular protein kinase cascade | 1.167794e-3 |
GO:0051896 | regulation of protein kinase B signaling cascade | 1.171042e-3 |
GO:0090068 | positive regulation of cell cycle process | 1.172020e-3 |
GO:0006346 | methylation-dependent chromatin silencing | 1.176733e-3 |
GO:0043551 | regulation of phosphatidylinositol 3-kinase activity | 1.184747e-3 |
GO:0021953 | central nervous system neuron differentiation | 1.222512e-3 |
GO:0006401 | RNA catabolic process | 1.229587e-3 |
GO:0006402 | mRNA catabolic process | 1.236642e-3 |
GO:0070979 | protein K11-linked ubiquitination | 1.240590e-3 |
GO:0046512 | sphingosine biosynthetic process | 1.283139e-3 |
GO:0060192 | negative regulation of lipase activity | 1.333741e-3 |
GO:0042158 | lipoprotein biosynthetic process | 1.360528e-3 |
GO:0045059 | positive thymic T cell selection | 1.371132e-3 |
GO:0055099 | response to high density lipoprotein particle stimulus | 1.379066e-3 |
GO:0000077 | DNA damage checkpoint | 1.382471e-3 |
GO:0034614 | cellular response to reactive oxygen species | 1.401016e-3 |
GO:0051937 | catecholamine transport | 1.402104e-3 |
GO:0045830 | positive regulation of isotype switching | 1.421916e-3 |
GO:0050794 | regulation of cellular process | 1.460804e-3 |
GO:0010517 | regulation of phospholipase activity | 1.516279e-3 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 1.517025e-3 |
GO:0032878 | regulation of establishment or maintenance of cell polarity | 1.529988e-3 |
GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation | 1.550460e-3 |
GO:0008284 | positive regulation of cell proliferation | 1.627960e-3 |
GO:0021987 | cerebral cortex development | 1.668278e-3 |
GO:0001101 | response to acid | 1.704412e-3 |
GO:0072659 | protein localization in plasma membrane | 1.713459e-3 |
GO:0021960 | anterior commissure morphogenesis | 1.734364e-3 |
GO:0002175 | protein localization to paranode region of axon | 1.736124e-3 |
GO:0033135 | regulation of peptidyl-serine phosphorylation | 1.749011e-3 |
GO:0031570 | DNA integrity checkpoint | 1.780856e-3 |
GO:0007015 | actin filament organization | 1.817710e-3 |
GO:0070873 | regulation of glycogen metabolic process | 1.869059e-3 |
GO:0019218 | regulation of steroid metabolic process | 1.869735e-3 |
GO:0032717 | negative regulation of interleukin-8 production | 1.936656e-3 |
GO:0009123 | nucleoside monophosphate metabolic process | 1.938111e-3 |
GO:0051129 | negative regulation of cellular component organization | 1.954318e-3 |
GO:0090073 | positive regulation of protein homodimerization activity | 1.958793e-3 |
GO:0044248 | cellular catabolic process | 1.973269e-3 |
GO:0060740 | prostate gland epithelium morphogenesis | 1.980552e-3 |
GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation | 2.042894e-3 |
GO:0031103 | axon regeneration | 2.042894e-3 |
GO:0048304 | positive regulation of isotype switching to IgG isotypes | 2.074074e-3 |
GO:0065007 | biological regulation | 2.092130e-3 |
GO:0045070 | positive regulation of viral genome replication | 2.093212e-3 |
GO:0031017 | exocrine pancreas development | 2.100901e-3 |
GO:0002376 | immune system process | 2.101145e-3 |
GO:0060512 | prostate gland morphogenesis | 2.113880e-3 |
GO:0032386 | regulation of intracellular transport | 2.117391e-3 |
GO:0019725 | cellular homeostasis | 2.171309e-3 |
GO:0031123 | RNA 3'-end processing | 2.199612e-3 |
GO:0045911 | positive regulation of DNA recombination | 2.223036e-3 |
GO:0002524 | hypersensitivity | 2.237398e-3 |
GO:0046887 | positive regulation of hormone secretion | 2.238406e-3 |
GO:0009057 | macromolecule catabolic process | 2.295773e-3 |
GO:0060765 | regulation of androgen receptor signaling pathway | 2.349728e-3 |
GO:0010001 | glial cell differentiation | 2.360008e-3 |
GO:0045588 | positive regulation of gamma-delta T cell differentiation | 2.389952e-3 |
GO:0001820 | serotonin secretion | 2.406935e-3 |
GO:0048505 | regulation of timing of cell differentiation | 2.447722e-3 |
GO:0007008 | outer mitochondrial membrane organization | 2.472739e-3 |
GO:0065008 | regulation of biological quality | 2.489853e-3 |
GO:0010675 | regulation of cellular carbohydrate metabolic process | 2.534765e-3 |
GO:0030279 | negative regulation of ossification | 2.542606e-3 |
GO:0032268 | regulation of cellular protein metabolic process | 2.545288e-3 |
GO:0006631 | fatty acid metabolic process | 2.561231e-3 |
GO:0001974 | blood vessel remodeling | 2.589905e-3 |
GO:0006446 | regulation of translational initiation | 2.604027e-3 |
GO:0050896 | response to stimulus | 2.610394e-3 |
GO:0010876 | lipid localization | 2.629689e-3 |
GO:0023021 | termination of signal transduction | 2.633367e-3 |
GO:0071205 | protein localization to juxtaparanode region of axon | 2.633367e-3 |
GO:0042596 | fear response | 2.669698e-3 |
GO:0045844 | positive regulation of striated muscle tissue development | 2.721049e-3 |
GO:0003231 | cardiac ventricle development | 2.778636e-3 |
GO:0006109 | regulation of carbohydrate metabolic process | 2.784768e-3 |
GO:0050655 | dermatan sulfate proteoglycan metabolic process | 2.858182e-3 |
GO:0070534 | protein K63-linked ubiquitination | 2.873887e-3 |
GO:0046626 | regulation of insulin receptor signaling pathway | 2.894159e-3 |
GO:0046477 | glycosylceramide catabolic process | 2.899246e-3 |
GO:0060527 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis | 2.910667e-3 |
GO:0007007 | inner mitochondrial membrane organization | 2.910667e-3 |
GO:0048311 | mitochondrion distribution | 2.971484e-3 |
GO:0007193 | inhibition of adenylate cyclase activity by G-protein signaling pathway | 3.057443e-3 |
GO:0040034 | regulation of development, heterochronic | 3.104695e-3 |
GO:0033025 | regulation of mast cell apoptosis | 3.182898e-3 |
GO:0014902 | myotube differentiation | 3.202096e-3 |
GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway | 3.226354e-3 |
GO:0046456 | icosanoid biosynthetic process | 3.245316e-3 |
GO:0043255 | regulation of carbohydrate biosynthetic process | 3.275555e-3 |
GO:0030032 | lamellipodium assembly | 3.311355e-3 |
GO:0072661 | protein targeting to plasma membrane | 3.324650e-3 |
GO:2001108 | positive regulation of Rho guanyl-nucleotide exchange factor activity | 3.347365e-3 |
GO:0034126 | positive regulation of MyD88-dependent toll-like receptor signaling pathway | 3.347365e-3 |
GO:2000727 | positive regulation of cardiac muscle cell differentiation | 3.351682e-3 |
GO:0051387 | negative regulation of nerve growth factor receptor signaling pathway | 3.397263e-3 |
GO:0033627 | cell adhesion mediated by integrin | 3.397263e-3 |
GO:0032922 | circadian regulation of gene expression | 3.397263e-3 |
GO:0021801 | cerebral cortex radial glia guided migration | 3.425324e-3 |
GO:0048534 | hemopoietic or lymphoid organ development | 3.431626e-3 |
GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway | 3.455247e-3 |
GO:0033144 | negative regulation of steroid hormone receptor signaling pathway | 3.480751e-3 |
GO:0006399 | tRNA metabolic process | 3.543657e-3 |
GO:0044238 | primary metabolic process | 3.544793e-3 |
GO:0035024 | negative regulation of Rho protein signal transduction | 3.629888e-3 |
GO:0051017 | actin filament bundle assembly | 3.659304e-3 |